Health X Platform files FY26 BRSR with BSE and NSE exchanges
- Health X Platform filed its FY26 BRSR with BSE and NSE on September 4, 2026
- Paid-up capital stands at ₹3181.05 lakhs with consolidated reporting basis
- Wholesale pharmaceutical trading contributes 98.80% of total turnover
- No assurance provider was engaged for the sustainability report

*this image is generated using AI for illustrative purposes only.
Health X Platform Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY26 to the Bombay Stock Exchange and National Stock Exchange on September 4, 2026. The filing provides consolidated disclosures on the company’s operational and sustainability metrics.
The report was filed pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is also available on the company’s website. Pratap Singh, Company Secretary and Compliance Officer, signed the document.
General Disclosures
The listed entity, formerly known as Sastasundar Ventures Limited, was incorporated on June 6, 1989. Its registered and corporate office is located in Kolkata. The paid-up capital stands at ₹3181.05 lakhs. The reporting boundary for this BRSR is on a consolidated basis. No assurance provider was engaged for this report.
| Detail | Information |
|---|---|
| CIN | L65993WB1989PLC047002 |
| Paid-up Capital | ₹3181.05 lakhs |
| Reporting Basis | Consolidated |
| Assurance Provider | Not Applicable |
Business Activities
Wholesale trading of pharmaceutical and OTC products accounts for 98.80% of the entity’s turnover. Other financial service activities contribute a negligible 0.002%. The company operates under NIC codes 46497 and 46901 for its primary wholesale activities.
| Activity | % of Turnover |
|---|---|
| Wholesale of pharmaceutical/medical goods | 98.80% |
| Other Financial Service activities | 0.002% |
Historical Stock Returns for Health X Platform
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.82% | +2.30% | -4.67% | +7.42% | +8.96% | +2.72% |
How might the lack of an independent assurance provider for this BRSR impact investor confidence in Health X's sustainability claims compared to peers?
Given that 98.8% of turnover comes from pharmaceutical wholesale, what specific sustainability risks related to supply chain logistics or regulatory compliance is the company prioritizing in FY27?
Will Health X Platform initiate a strategic pivot to diversify its revenue streams beyond wholesale trading to mitigate concentration risk in the coming fiscal years?


































